<DOC>
	<DOCNO>NCT00289952</DOCNO>
	<brief_summary>The purpose study examine whether co-administration valproic acid ( Epival® ) , highly active antiretroviral therapy ( HAART ) reduce size HIV latent reservoir infect CD4 cell .</brief_summary>
	<brief_title>Valproic Acid Its Effects HIV Latent Reservoirs</brief_title>
	<detailed_description>Participants must HAART suppressed viral load ( &lt; 50 copies/ml ) least previous 12 month . They randomly assign one two group , one group start valproic acid right away week 1 16 week , group wait week 17 add valproic acid treatment 32 week . Subjects follow every four week one year evaluate variety assay , carry use well-established method , ass main outcome define change HIV reservoir size measure mean frequency rest CD4 memory cell carry HIV proviral DNA .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Valproic Acid</mesh_term>
	<mesh_term>Histone Deacetylase Inhibitors</mesh_term>
	<criteria>Documented HIV seropositive infection Western Blot , EIA assay viral load . Aged 18 year old old . Viral load &lt; 50 copies/ml least previous 12 month . Circulating CD4+ cell count ³ 200 cells/ml . Taking HAART . Vital sign , physical examination laboratory result exhibit evidence disease advance cirrhosis advance liver disease ( ALT AST &gt; 5 x upper limit normal value ) . Karnofsky performance status 80 % . Subject require agrees take , duration study , medication contraindicate VPA . Willing able give inform consent . All participant agree abstinence use effective method contraception study . Pregnant breastfeed woman . Psychiatric cognitive disturbance illness could preclude compliance study . Current use use within four week prior baseline visit , cytotoxic agent , systemic corticosteroid immunomodulatory agent intravenous immunoglobulin , hydroxyurea . HIV vaccine within six month screen visit Allergic reaction VPA . Active intravenous drug user . History bleed disorder . Unstable treated hypertension . Pasthistory pancreatitis chronic liver disease ( ALT AST &gt; 5 x upper limit normal value ) . However subject coinfected hepatitis B C participate ALT AST &lt; 5 x upper limit normal value . Renal failure ( creatinine &gt; 2 x upper limit normal value ) . Ammonemia ( &gt; 2x upper limit normal value ) . Taking Zidovudine ( AZT ) , combination drug contain AZT like Combivir Trizivir . However subject ask switch another NRTI , least two week prior Valproic Acid initiation , become eligible . Taking daily basis : phenytoin , carbamazepine , phenobarbital , warfarin aspirin . Subject follow abnormal laboratory result Hemoglobin &lt; 100 g/L . Absolute neutrophil count &lt; 0.75 x 10 9 cells/L . Platelet count &lt; 50 x 10 9 cells/L . Subject suffer urea cycle disorder .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2008</verification_date>
	<keyword>HIV infection</keyword>
	<keyword>Histone deacetylase Inhibitor</keyword>
	<keyword>HIV Reservoirs</keyword>
	<keyword>Peripheral Blood Mononuclear Cells</keyword>
	<keyword>Valproic Acid</keyword>
	<keyword>Treatment Experienced</keyword>
</DOC>